Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xtant Medical Holdings (XTNT) Liabilities and Shareholders Equity (2016 - 2025)

Xtant Medical Holdings has reported Liabilities and Shareholders Equity over the past 16 years, most recently at $94.1 million for Q4 2025.

  • Quarterly Liabilities and Shareholders Equity changed 0.33% to $94.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $399.8 million through Dec 2025, up 4.59% year-over-year, with the annual reading at $94.1 million for FY2025, 0.33% changed from the prior year.
  • Liabilities and Shareholders Equity was $94.1 million for Q4 2025 at Xtant Medical Holdings, down from $106.3 million in the prior quarter.
  • Over five years, Liabilities and Shareholders Equity peaked at $106.3 million in Q3 2025 and troughed at $52.7 million in Q2 2022.
  • The 5-year median for Liabilities and Shareholders Equity is $78.6 million (2023), against an average of $77.3 million.
  • Year-over-year, Liabilities and Shareholders Equity fell 11.67% in 2022 and then surged 64.15% in 2023.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $54.7 million in 2021, then increased by 10.12% to $60.2 million in 2022, then skyrocketed by 53.77% to $92.6 million in 2023, then increased by 1.32% to $93.8 million in 2024, then increased by 0.33% to $94.1 million in 2025.
  • Per Business Quant, the three most recent readings for XTNT's Liabilities and Shareholders Equity are $94.1 million (Q4 2025), $106.3 million (Q3 2025), and $103.5 million (Q2 2025).